<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02820688</url>
  </required_header>
  <id_info>
    <org_study_id>ANES-IK-0609</org_study_id>
    <nct_id>NCT02820688</nct_id>
  </id_info>
  <brief_title>Concentration-Volume Relationship in Infraclavicular Block</brief_title>
  <official_title>Impact of Local Anesthetic Concentration-Volume Modifications on Ultrasound Guided Infraclavicular Nerve Block Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bozyaka Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bozyaka Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized, double blind study aims to determine the optimal volume for
      adequate sensorial and motor blockade following an infraclavicular block. Patients will be
      randomized into three groups. Using a constant dose of local anesthetics (45mg bupivacaine
      180mg prilocaine), different volumes will be used in each of the groups (First group; 18mL,
      second group; 27mL, third group; 36mL). Onset, duration and quality of sensory and motor
      block will be compared for patients between groups
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although ultrasound guided infraclavicular nerve block is routinely used to provide
      anesthesia for almost all of the upper extremity surgeries, optimal volume and concentration
      of locak anesthetic to be administered is still a subject of debate. This prospective,
      randomized, double blind study aims to determine the optimal volume for adequate sensorial
      and motor blockade following an infraclavicular block. Patients will be randomly allocated
      into three groups. 81 patients (27 in each group) are planned to be enrolled in this study
      due to a power analysis performed (G-power ver 3.1). Using a constant dose of local
      anesthetics (45mg bupivacaine 180mg prilocaine), different volumes will be used in each of
      the groups (First group; 18mL, second group; 27mL, third group; 36mL). Onset, duration and
      quality of sensory and motor block will be compared for patients between groups Researchers
      who perform the block and assess the block quality and onset will be blinded to patients'
      groups. Patients will also be blinded to groups they are assigned.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensory Block, as assessed by hollman scale for pinprick test</measure>
    <time_frame>0, 3rd, 6th, 9th, 12th, 20th, 25th, 30th minute</time_frame>
    <description>Sensorial response to pinprick will be assessed at innervation sites of ulnar median radial and musculocutaneous nerves. Innervation sites of assessment are volar skin of the fifth finger for ulnar nerve, volar skin of second finger for median nerve and dorsal, proximal of the second finger for radial nerve and skin of the anterolateral forearm for musculocutaneous nerve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motor Block, as assessed by hollman scale for motor blockade</measure>
    <time_frame>0, 3rd, 6th, 9th, 12th, 20th, 25th, 30th minute</time_frame>
    <description>Motor function for each nerve will be assessed. Movements to be evaluated are; abduction of the fingers for ulnar nerve, thumb opposition for median nerve, extension of the forearm for radial nerve and flexion of the forearm for musculocutaneous nerve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Sensory Block, as assessed by hollman scale for pinprick test</measure>
    <time_frame>1th hour in PACU</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Motor Block, as assessed by hollman scale for motor blockadet</measure>
    <time_frame>1th hour in PACU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain, as assessed by visual analogue scale</measure>
    <time_frame>1st hour and 6th hour</time_frame>
    <description>In addition, patients' first complaint time of pain will be recorded by nurse</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Brachial Plexus Blockade</condition>
  <arm_group>
    <arm_group_label>Concentrated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infraclavicular nerve block under guidance of ultrasonography will be performed using an undiluted solution of 45mg bupivacaine and 180mg prilocaine (bupivacaine 0.25% and prilocaine 1%, 18mL in total) to patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diluted by 33%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infraclavicular nerve block under guidance of ultrasonography will be performed using a solution of 45mg bupivacaine and 180mg prilocaine diluted by 33% (bupivacaine 0.167% and prilocaine 0.66%, 27mL in total) to patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diluted by 50%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infraclavicular nerve block under guidance of ultrasonography will be performed using a solution of 45mg bupivacaine and 180mg prilocaine diluted by 50% (bupivacaine 0.125% and prilocaine 0.5%, 36mL in total) to patients in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.25%</intervention_name>
    <arm_group_label>Concentrated</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine 1%</intervention_name>
    <arm_group_label>Concentrated</arm_group_label>
    <other_name>Citanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Infraclavicular Nerve Block</intervention_name>
    <description>Ultrasound guided infraclavicular nerve block</description>
    <arm_group_label>Concentrated</arm_group_label>
    <arm_group_label>Diluted by 33%</arm_group_label>
    <arm_group_label>Diluted by 50%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.167%</intervention_name>
    <arm_group_label>Diluted by 33%</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.125%</intervention_name>
    <arm_group_label>Diluted by 50%</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine 0.66%</intervention_name>
    <arm_group_label>Diluted by 33%</arm_group_label>
    <other_name>Citanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine 0.5%</intervention_name>
    <arm_group_label>Diluted by 50%</arm_group_label>
    <other_name>Citanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>All nerve blocks will be performed with ultrasound guidance</description>
    <arm_group_label>Concentrated</arm_group_label>
    <arm_group_label>Diluted by 33%</arm_group_label>
    <arm_group_label>Diluted by 50%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for upper extremity surgery with infraclavicular nerve block

        Exclusion Criteria:

          -  Patient Refusal

          -  Patients younger than 18

          -  Patients with known local anesthetic allergies

          -  Patients with a BMI&gt;30

          -  Diabetic Patients

          -  Uncooperated Patients

          -  Patients with coagulopathy or recieving anticoagulant therapy

          -  Skin infection on injection site

          -  Patients diagnosed with sepsis or bacteremia

          -  Physiologic and emotional lability

          -  Surgeries that are expected to last longer than 3 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeki T Tekgul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Bozyaka Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Izmir Bozyaka Training and Research Hospital</name>
      <address>
        <city>Izmir</city>
        <zip>35170</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Mosaffa F, Gharaei B, Qoreishi M, Razavi S, Safari F, Fathi M, Mohseni G, Elyasi H, Hosseini F. Do the Concentration and Volume of Local Anesthetics Affect the Onset and Success of Infraclavicular Anesthesia? Anesth Pain Med. 2015 Aug 22;5(4):e23963. doi: 10.5812/aapm.23963v2. eCollection 2015 Aug.</citation>
    <PMID>26473102</PMID>
  </reference>
  <reference>
    <citation>González AP, Bernucci F, Techasuk W, Pham K, Finlayson RJ, Tran DQ. A randomized comparison between 3 combinations of volume and concentration of lidocaine for ultrasound-guided infraclavicular block. Reg Anesth Pain Med. 2013 May-Jun;38(3):206-11. doi: 10.1097/AAP.0b013e318287fe53.</citation>
    <PMID>23518863</PMID>
  </reference>
  <reference>
    <citation>Fenten MG, Schoenmakers KP, Heesterbeek PJ, Scheffer GJ, Stienstra R. Effect of local anesthetic concentration, dose and volume on the duration of single-injection ultrasound-guided axillary brachial plexus block with mepivacaine: a randomized controlled trial. BMC Anesthesiol. 2015 Sep 30;15:130. doi: 10.1186/s12871-015-0110-0.</citation>
    <PMID>26423050</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>January 4, 2017</last_update_submitted>
  <last_update_submitted_qc>January 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Local Anesthtetics</keyword>
  <keyword>Nerve Block</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Prilocaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

